abstract |
The present invention relates generally to the 8-azaprostanoid analogues represented by Formula I, their synthesis and their use for treating osteoporosis and increasing bone density, which are generally EP 4 receptor agonists:n n n n n n n n Wherein Q, B, X, J, Z, A and R 1 -R 6 are as defined in the detailed description. |